QPTFF (Quest PharmaTech) Total Liabilities: $0.97 Mil (As of Jan. 2026)


What is Quest PharmaTech Total Liabilities?

Quest PharmaTech QPTFF Total Liabilities is $0.97 Mil as of Jan. 2026.

Quest PharmaTech's Total Liabilities for the quarter that ended in Jan. 2026 was $0.97 Mil.

Quest PharmaTech's quarterly Total Liabilities increased from Jul. 2025 ($0.86 Mil) to Oct. 2025 ($0.90 Mil) and increased from Oct. 2025 ($0.90 Mil) to Jan. 2026 ($0.97 Mil).

Quest PharmaTech's annual Total Liabilities declined from Jan. 2024 ($0.99 Mil) to Jan. 2025 ($0.81 Mil) but then increased from Jan. 2025 ($0.81 Mil) to Jan. 2026 ($0.97 Mil).

Quest PharmaTech Total Liabilities Historical Data

* Premium members only.

The historical data trend for Quest PharmaTech's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Quest PharmaTech Total Liabilities Chart

Quest PharmaTech Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.49 0.82 0.99 0.81 0.97

Quest PharmaTech Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.81 0.77 0.86 0.90 0.97

Quest PharmaTech Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Quest PharmaTech's Total Liabilities for the fiscal year that ended in Jan. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.965+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=0.97

Total Liabilities=Total Assets (A: Jan. 2026 )-Total Equity (A: Jan. 2026 )
=20.154-19.19
=0.96

Quest PharmaTech's Total Liabilities for the quarter that ended in Jan. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.965+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=0.97

Total Liabilities=Total Assets (Q: Jan. 2026 )-Total Equity (Q: Jan. 2026 )
=20.154-19.19
=0.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $0.97 Mil mean?
Quest PharmaTech (QPTFF) has a Total Liabilities of $0.97 Mil as of Jan. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Quest PharmaTech and its competitors.
Is Quest PharmaTech's Total Liabilities too high?
Quest PharmaTech's current Total Liabilities is $0.97 Mil.
How does Quest PharmaTech's Total Liabilities compare to VRTX and REGN?
Quest PharmaTech's Total Liabilities of $0.97 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Quest PharmaTech and its competitors. Quest PharmaTech's current Total Liabilities is $0.97 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quest PharmaTech stock overvalued right now?
Quest PharmaTech (QPTFF) has a current Total Liabilities of $0.97 Mil. The current Total Liabilities is $0.97 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Quest PharmaTech (QPTFF), the current Total Liabilities is $0.97 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Quest PharmaTech Business Description

Other Exchanges QPT:Canada
Address 4342- 97 Street NW, Edmonton, AB, CAN, T6E 5R9
Quest PharmaTech Inc is developing targeted cancer therapy with its product (MAb AR9.6), under development for a novel target (truncated O-glycans on MUC16) discovered at the University of Nebraska Medical Center.